Sam Paglinco, DO
@SamPaglinco
Followers
99
Following
195
Media
9
Statuses
88
IBD advocate, physician and patient • Peds GI 💩• sloth lover 🦥• trying to make the world a better place 🌎• tweets are my own and not medical advice
Joined March 2022
It has been an amazing 3 years @RossMaltz. I can’t believe it is an end of an era. You have taught me so much and I still have so much to learn from you. I will make a list of things you still have to teach me for our next research meeting.
So sad to see my mentee, GI fellow, researcher, and friend @SamPaglinco graduate and move on to great things. I know we will keep in touch especially since we have a research meeting on July 2nd. Picture from a card she gave me. A picture of us holding her research award.
0
1
2
Day on the Hill with colleagues from @naspghan: we discussed legislation (#MNEA & #StepTherapy) critical to patient care and access for children and young adults living with chronic GI illnesses including #IBD #EOE @BenjamminGold @SamPaglinco @csbonta @DrEllPeds @anildarbari
0
3
19
State and federal lawmakers need to stop insurance companies and PBMs from practicing medicine without a license. Make no mistake, insurers, PBMs and Rx companies are all complicit. Where’s the transparency?
NASPGHAN member @DrPasternak_IBD speaks before AZ Senate Finance & Commerce Cmte in favor of #SB1164 to restrict PBM non-medical switching. #NASPGHAN calls for swift passage of SB1164. #StateAdvocacy @AZSenateDems @AZSenateRepublicans @AZHouseGOP @AZHouseDems
0
2
4
This week Cigna said it would be spending $11.3 billion not to lower premiums, deductibles, or improve health care for its policy holders, but to buy back its stock to make its executives and stockholders even richer. This is what a corrupt & broken health care system looks like.
384
1K
4K
Everyone doubted us. Said we couldn't impact an industry that no one trusts. Here we are less than 2 years later announcing we are adding ONE THOUSAND+ new drugs, bringing our total to more than 2,200 !!! It's time to check again to see if https://t.co/LYIIV9Pqzd carries your
costplusdrugs.com
Mark Cuban Cost Plus Drug homepage. Provides safe, affordable medicine or medication with transparent low prices.
📍 On January 19th, 2022, Cost Plus Drugs launched with 100 drugs... TODAY we are excited and proud to announce that we are adding OVER 1,000 NEW MEDICATIONS! 🚨 📢 This bring our total to 2,200+ medications on https://t.co/DbEuAEZQYV! ✚ Go to https://t.co/Hryd1b149a to see if
314
760
7K
Just part of the @nationwidekids GI team at our @OhioStateFB tailgate yesterday. 10-0 and not done yet. Go Bucks! @MGrishamMD @RossMaltz @RSanchez490MD @CarloDiLorenzo1 @LauraHamant @deslilo @juliavdzande @NDavidsonMD @jsmkhoo @JenniferLeeLee1 @SamPaglinco
0
4
36
This editorial is🌟in many ways 🫶🏾Partnering w @ReezwanaCMD who was my GI fellow & now an IBD colleague💜 🔎@tinahamd & al. work #RectalUrgency 📈16-20% of #IBD ⬆️ w active🔥 ⬇️QOL, sleep, work 🤝Should be a 🎯 in pt-centered Q & approach to IBD Rx 🔗 https://t.co/3JRtMYYv3l
@DCharabaty recommends in her editorial ( https://t.co/ksvfifVlGH) including rectal urgency w/ dz activity, decreased work productivity, & QOL in #UC & #CD in clinical care and as a clinical endpoint in #IBD therapeutic trials, based on a recent global study by @tinahamd
1
18
52
Losses of exclusivity for biologics and intro of biosimilars have increased in the past three years, with brand sales of those products dropping by $33Bn over the past five years compared to $4Bn over the prior five years and reflecting a growing role for biosimilars.
0
4
6
🦥🦥🦥 are going to have a hard time escaping! We really need to find a good hiding place!! @SamPaglinco @MGrishamMD
@NCHforFellows
0
1
9
It is really hard to do proactive TDM with adalimumab. (Since it requires an extra trip to the lab right before an injection). This is an important consideration when doing shared decision with families on initiating infliximab or adalimumab. @andrewbgrossman #ICNCCF23
0
1
8
“Only” 10 years old yet possessing poise, passion and leadership skills surpassing those far older: Samantha and her wonderful #PedsGI doc @DrPasternak_IBD taught us the power of what our children can do and teach us at #ICNCC23F @ImproveCareNow
0
3
12
Wouldn’t have been able to do this without the mentorship and emotional support of @RossMaltz and the very data driven #TwitterlessBoyle
#ICNCCF23
So proud of my mentee @SamPaglinco presenting NCH data on the importance of checking infliximab levels early(@ week 6)
0
0
4
“Stay strong and you’ll do great.” Words of wisdom from a 10 y.o. powerhouse IBDer. ✨ #ICNCCF23 @ImproveCareNow @ICNPatients
2
4
6
Learning about how early, appropriate use of surgery in #IBD is an important tool from @MLongMD, so essential to remember and check out the pediatric IBD & surgery #SDM tool and study from @ImproveCareNow! @ICNPatients #ICNCCF23 Learn more here!:
improvecarenow.org
0
3
2
Confused 🤷🏻♀️🤷🏻♂️on all of the adalimumab biosimilars and the difference among them?! Me too! I can’t keep the differences straight. Below is an awesome resource for information on adalimumab biosimilars! #ICNCCF23
0
2
2
We have work to do 💪🏼to close the gaps of inequities so ALL children get the care they deserve. Addressing social determinants of health is important. #ICNCCF23
Ongoing call to action for our community to meaningfully and sustainably address inequities in pediatric #IBD for *all* our kids to have accessible, equitable, interdisciplinary, & excellent care @ImproveCareNow @ICNPatients #ICNCCF23
0
2
7
Congratulations to Jen Dotson for being the Southern Ohio @CrohnsColitisFn United to Care & Cure Award Winner! I am humbled to work and learn from her at @nationwidekids as she continues to advocate and care for children with IBD. #twitterlessJenDotson
0
1
6
The 2023 NASPGHAN Foundation/CPNP Nutrition Grant Recipient is Jen Smith with the grant titled “Prevalence of Avoidant/Restrictive Intake Food Disorder (ARFID) in adolescents with inflammatory bowel disease.”
0
2
18
👇🏼👇🏼An important reason why we should use our voice to advocate for the Safe Step Act. Send a message to your representatives here:
votervoice.net
The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) has endorsed bipartisan legislation pending in the U.S. Senate and House of Representatives that has the...
👇🏼👇🏼Treatment denial and delay of necessary care causes harm.
0
3
4